Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2964 |  DMAC DiaMedica Therapeutics Inc. - Common Stock | 8.01 USD | +0.25% | -5.65% | +21.92% | +14.92% | 431.94 M USD | ||
| 2978 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 9.15 USD | -2.24% | -5.67% | -32.17% | -51.84% | 424.36 M USD | ||
| 2991 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 5.16 USD | +2.99% | 0.00% | -1.15% | +60.75% | 413.86 M USD | ||
| 2998 |  YDES YD Bio Limited - Ordinary Shares | 5.79 USD | -1.53% | -24.90% | +51.57% | -69.04% | 409.87 M USD | ||
| 3019 |  DRUG Bright Minds Biosciences Inc. - common stock | 52.00 USD | 0.00% | +5.39% | -18.72% | -15.72% | 397.06 M USD | ||
| 3020 |  ZURA Zura Bio Limited - Class A Ordinary shares | 4.13 USD | -0.96% | -1.90% | -25.32% | -5.28% | 395.77 M USD | ||
| 3049 |  KYTX Kyverna Therapeutics, Inc. - Common Stock | 6.18 USD | +0.16% | -6.65% | -17.71% | -12.09% | 382.19 M USD | ||
| 3066 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.63 USD | +2.61% | +1.63% | -7.65% | +15.04% | 372.76 M USD | ||
| 3071 |  IRD Opus Genetics, Inc. - Common Stock | 4.46 USD | +1.13% | -2.19% | -24.15% | +19.89% | 371.05 M USD | ||
| 3078 |  GALT Galectin Therapeutics Inc. - Common Stock | 3.64 USD | +0.55% | -4.71% | -9.00% | -23.69% | 367.09 M USD | ||
| 3082 |  ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 12.87 USD | +0.78% | -3.45% | -10.06% | -35.55% | 365.80 M USD | ||
| 3109 |  ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 12.10 USD | -2.18% | -6.71% | -7.56% | +5.13% | 352.42 M USD | ||
| 3114 |  CCCC C4 Therapeutics, Inc. - Common Stock | 2.85 USD | +1.06% | -10.66% | -16.18% | +15.85% | 350.62 M USD | ||
| 3129 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.73 USD | +1.24% | -10.47% | -0.17% | +96.91% | 344.40 M USD | ||
| 3139 |  AGEN Agenus Inc. - Common Stock | 7.54 USD | -0.40% | -9.81% | +11.54% | +77.00% | 339.45 M USD | ||
| 3140 |  TTRX Turn Therapeutics Inc. - Common Stock | 11.39 USD | -5.87% | -14.68% | -14.62% | +38.06% | 339.29 M USD | ||
| 3142 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 3.17 USD | -2.46% | -14.78% | -25.41% | +41.52% | 338.14 M USD | ||
| 3156 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 6.80 USD | -2.86% | -1.31% | -36.45% | +63.46% | 332.45 M USD | ||
| 3158 |  OCGN Ocugen, Inc. - Common Stock | 0.98 USD | -2.00% | -5.77% | -10.91% | -46.15% | 332.33 M USD | ||
| 3162 |  CABA Cabaletta Bio, Inc. - Common Stock | 1.95 USD | -1.02% | +0.52% | -31.58% | -38.29% | 330.61 M USD |
뉴스 Biotechnology Stocks
RBC 캐피털, 리듬 파마슈티컬스에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 159달러로 상향
RBC 캐피털, 엑셀리시스 투자의견 ‘시장수익률’ 유지·목표주가 45달러로 하향
ADC 테라퓨틱스, 주당 1.42달러에 1,290만 주 및 주당 1.32달러에 4,810만 주 매입 워런트 제공하는 8,660만 달러 규모 파이프 파이낸싱 발표; 대출 및 로열티 수정 확보
뉴트리밴드, AVERSA 남용 억제 경피 기술 보호 강화 위해 미국 특허 출원
바이오라인RX, GLIX1 관련 초록 2편이 11월 12~15일 신경종양학회 연례회의에서 발표될 예정이라고 발표
아트리움 테라퓨틱스, 5,170,384주 및 사전 자금 조달 워런트 최대 1,134,930주 매입을 위한 약 7.93달러/주당 5천만 달러 규모의 사모 발표
러시아, 시베리아에서 두 번째 발병 사례 보도 부인 - 블룸버그
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |